Chih-Wen Wang

10PUBLICATIONS
20CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursEpidemiological methodsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 22, 2025
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

Ya-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang

|Jul 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B.

Tyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang

|Nov 26, 2024
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

Tyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang

|Jul 10, 2024
Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality.

Chih-Wen Wang, Chung-Feng Huang, Ming-Lun Yeh

|Mar 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.

Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun

|Feb 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma.

Chih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang

Pageof 2